All Stocks/Healthcare/RXRX

RECURSION PHARMACEUTICALS, INC.

RXRX
HealthcareBiotechnology Website
Price ChartPowered by TradingView
Ask about RXRXAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
ARK Invest
Cathie Wood
37.32M$152.63MNEW
Citadel
Ken Griffin
8.17M$33.43MNEW
Point72
Steve Cohen
654K$2.68MNEW
Marshall Wace227K$926.8KNEW
D.E. Shaw
David Shaw
90K$366.2KNEW
About RECURSION PHARMACEUTICALS, INC.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on decoding biology to industrialize drug discovery. It integrates technological innovations across biology, chemistry, automation, data science, engineering, artificial intelligence, and machine learning to identify novel drug candidates, mechanisms of action, novel chemistry, and potential toxicity. The company's Recursion operating system powers advanced machine learning approaches for in vivo validation and advancing therapeutics aimed at improving patient lives. Operating in the healthcare sector, specifically biotechnology, Recursion Pharmaceuticals, Inc. develops medicines through its proprietary platform that combines automation with data-driven insights. Founded in 2013 and headquartered in Salt Lake City, Utah, it emphasizes reinvesting resources into growth-oriented research and development in the competitive biotech landscape.

CEO
Dr. Najat Khan Ph.D.
Employees
600
Quick Facts
Exchange
SectorHealthcare
IndustryBiotechnology
Market Cap
Key Dates

Earnings calendar coming soon. Subscribe to get notified when RXRX reports next.

Get earnings alerts →